Comparison of Risk Factors and 30 day-in Hospital mortality of Community-Acquired Pneumonia with Elderly Patients and Adult Patients: Using Secondary Data from the Korea Centers for Disease Control and Prevention
Abstract
Purpose: This study examines the factors influencing 30-day in-hospital mortality in elderly patients with community-acquired pneumonia (CAP) and compares them to those in adult patients.Methods: This secondary analysis used discharge data from the Korea Disease Control and Prevention Agency, covering the period from January 1, 2020, to December 31, 2022. Statistical methods included χ² tests, t-tests, the Cox proportional hazards model for calculating adjusted hazard ratios (HR), and Kaplan-Meier analysis. Results: The study found that older age (Adjusted HR=2.40, 95% CI=2.01-2.85, p<.001) and Emergency Room admissions (Adjusted HR=2.24, 95% CI=1.94-2.59, p<.001) are significantly associated with increased mortality in elderly patients. Other contributing factors include residency area (Adjusted HR=1.73, 95% CI=1.04-2.87, p=.035), hospital setting (Adjusted HR=1.34, 95% CI=1.05-1.70, p=.017), and the number of hospital beds (Adjusted HR=1.27, 95% CI=1.11-1.46, p=.001).Conclusion: These findings underscore the importance of improving community health screenings and developing respiratory infection prevention programs for elderly patients, especially those in high-risk areas.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.